1
Wit, Ferdinand W.N.M., Reiss, Peter, Rijnders, Bart, Rokx, Casper, Roukens, Anna, Brinkman, Kees, van der Valk, Marc
Veröffentlicht in: Wit , F W N M , Reiss , P , ATHENA cohort study group , Rijnders , B , Rokx , C , Roukens , A , Brinkman , K & van der Valk , M 2023 , ' COVID-19 in people with HIV in the Netherlands ' , AIDS (London, England) , vol. 37 , no. 11 , pp. 1671-1681 . https://doi.org/10.1097/QAD.0000000000003597;
2023
Veröffentlicht in: Wit , F W N M , Reiss , P , ATHENA cohort study group , Rijnders , B , Rokx , C , Roukens , A , Brinkman , K & van der Valk , M 2023 , ' COVID-19 in people with HIV in the Netherlands ' , AIDS (London, England) , vol. 37 , no. 11 , pp. 1671-1681 . https://doi.org/10.1097/QAD.0000000000003597;
2023
2
Boerekamps, Anne, Newsum, Astrid M, Smit, Colette, Arends, Joop E, Richter, Clemens, Reiss, Peter, Rijnders, Bart J A, Brinkman, Kees, van der Valk, Marc
Veröffentlicht in: Boerekamps , A , Newsum , A M , NVHB-SHM Hepatitis Working Group and the Netherlands ATHENA HIV Observational Cohort , Smit , C , Arends , J E , Richter , C , Reiss , P , Rijnders , B J A , Brinkman , K & van der Valk , M 2018 , ' High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands ' , Clinical Infectious Diseases , vol. 66 , no. 9 , pp. 1352-1359 . https://doi.org/10.1093/cid/cix1004;
2018
Veröffentlicht in: Boerekamps , A , Newsum , A M , NVHB-SHM Hepatitis Working Group and the Netherlands ATHENA HIV Observational Cohort , Smit , C , Arends , J E , Richter , C , Reiss , P , Rijnders , B J A , Brinkman , K & van der Valk , M 2018 , ' High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands ' , Clinical Infectious Diseases , vol. 66 , no. 9 , pp. 1352-1359 . https://doi.org/10.1093/cid/cix1004;
2018
3
Smit, Colette, Boyd, Anders, Rijnders, Bart J A, van de Laar, Thijs J W, Leyten, Eliane M, Bierman, Wouter F, Brinkman, Kees, Claassen, Mark A A, den Hollander, Jan, Boerekamps, Anne, Newsum, Astrid M, Schinkel, Janke, Prins, Maria, Arends, Joop E, Op de Coul, Eline L M, van der Valk, Marc, Reiss, Peter
Veröffentlicht in: Smit , C , Boyd , A , ATHENA National HIV Observational Cohort , Rijnders , B J A , van de Laar , T J W , Leyten , E M , Bierman , W F , Brinkman , K , Claassen , M A A , den Hollander , J , Boerekamps , A , Newsum , A M , Schinkel , J , Prins , M , Arends , J E , Op de Coul , E L M , van der Valk , M & Reiss , P 2021 , ' HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals : a retrospective cohort study ' , The Lancet HIV , vol. 8 , no. 2 , pp. e96-e105 . https://doi.org/10.1016/S2352-3018(20)30301-5;
2021
Veröffentlicht in: Smit , C , Boyd , A , ATHENA National HIV Observational Cohort , Rijnders , B J A , van de Laar , T J W , Leyten , E M , Bierman , W F , Brinkman , K , Claassen , M A A , den Hollander , J , Boerekamps , A , Newsum , A M , Schinkel , J , Prins , M , Arends , J E , Op de Coul , E L M , van der Valk , M & Reiss , P 2021 , ' HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals : a retrospective cohort study ' , The Lancet HIV , vol. 8 , no. 2 , pp. e96-e105 . https://doi.org/10.1016/S2352-3018(20)30301-5;
2021